ENTA – Enanta Pharmaceuticals Inc
ENTA — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
8.84
Margin Of Safety %
Put/Call OI Ratio
1.62
EPS Next Q Diff
-0.18
EPS Last/This Y
1.96
EPS This/Next Y
-0.17
Price
13.77
Target Price
21.57
Analyst Recom
1.14
Performance Q
-8.75
Upside
-513.8%
Beta
0.94
Ticker: ENTA
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | ENTA | 13.62 | 0.46 | 9.00 | 1078 |
| 2026-07-14 | ENTA | 13.11 | 0.46 | 9.00 | 1078 |
| 2026-07-15 | ENTA | 13.22 | 0.47 | 999.99 | 1088 |
| 2026-07-16 | ENTA | 13.16 | 0.50 | 0.73 | 1077 |
| 2026-07-17 | ENTA | 13.76 | 0.50 | 0.00 | 1111 |
| 2026-07-20 | ENTA | 13.17 | 0.29 | 999.99 | 525 |
| 2026-07-21 | ENTA | 13.39 | 0.56 | 999.99 | 635 |
| 2026-07-22 | ENTA | 13.06 | 0.64 | 999.99 | 666 |
| 2026-07-23 | ENTA | 12.93 | 1.35 | 999.99 | 956 |
| 2026-07-24 | ENTA | 12.76 | 1.48 | 999.99 | 1006 |
| 2026-07-27 | ENTA | 12.72 | 1.48 | 999.99 | 1006 |
| 2026-07-28 | ENTA | 12.62 | 1.48 | 5.19 | 1006 |
| 2026-07-29 | ENTA | 12.45 | 1.44 | 999.99 | 1027 |
| 2026-07-30 | ENTA | 13 | 1.45 | 0.40 | 1030 |
| 2026-07-31 | ENTA | 12.56 | 1.42 | 999.99 | 1044 |
| 2026-08-03 | ENTA | 12.97 | 1.65 | 999.99 | 1144 |
| 2026-08-04 | ENTA | 13.32 | 1.65 | 0.00 | 1144 |
| 2026-08-05 | ENTA | 13.23 | 1.62 | 6.00 | 1154 |
| 2026-08-07 | ENTA | 13.76 | 1.62 | 6.00 | 1154 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | ENTA | 13.62 | 40.0 | - | -1.88 |
| 2026-07-14 | ENTA | 13.10 | 40.0 | - | -1.88 |
| 2026-07-15 | ENTA | 13.23 | 40.0 | - | -1.88 |
| 2026-07-16 | ENTA | 13.17 | 40.0 | - | -1.88 |
| 2026-07-17 | ENTA | 13.74 | 40.0 | - | -1.88 |
| 2026-07-20 | ENTA | 13.15 | 40.0 | - | -1.88 |
| 2026-07-21 | ENTA | 13.40 | 40.0 | - | -1.88 |
| 2026-07-22 | ENTA | 13.04 | 40.0 | - | -1.88 |
| 2026-07-23 | ENTA | 12.95 | 40.0 | - | -1.88 |
| 2026-07-24 | ENTA | 12.75 | 40.0 | - | -1.88 |
| 2026-07-27 | ENTA | 12.75 | 40.0 | - | -1.88 |
| 2026-07-28 | ENTA | 12.62 | 40.0 | - | -1.88 |
| 2026-07-29 | ENTA | 12.44 | 40.0 | - | -1.88 |
| 2026-07-30 | ENTA | 12.97 | 40.0 | - | -1.88 |
| 2026-07-31 | ENTA | 12.59 | 40.0 | - | -1.88 |
| 2026-08-03 | ENTA | 12.95 | 40.0 | - | -1.88 |
| 2026-08-04 | ENTA | 12.95 | 40.0 | - | -1.88 |
| 2026-08-05 | ENTA | 13.23 | 40.0 | - | -1.88 |
| 2026-08-06 | ENTA | 13.31 | 40.0 | - | -1.88 |
| 2026-08-07 | ENTA | 13.77 | 40.0 | - | -1.88 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | ENTA | 0.00 | 0.16 | 9.36 |
| 2026-07-14 | ENTA | 0.00 | 0.16 | 9.36 |
| 2026-07-15 | ENTA | 0.00 | 0.16 | 9.36 |
| 2026-07-16 | ENTA | 0.00 | 0.16 | 9.36 |
| 2026-07-17 | ENTA | 0.00 | 0.16 | 9.36 |
| 2026-07-20 | ENTA | 0.00 | -0.13 | 9.36 |
| 2026-07-21 | ENTA | 0.00 | -0.13 | 9.36 |
| 2026-07-22 | ENTA | 0.00 | -0.13 | 9.36 |
| 2026-07-23 | ENTA | 0.00 | -0.13 | 9.36 |
| 2026-07-24 | ENTA | 0.00 | -0.13 | 9.36 |
| 2026-07-27 | ENTA | 0.00 | -0.11 | 8.84 |
| 2026-07-28 | ENTA | 0.00 | -0.11 | 8.84 |
| 2026-07-29 | ENTA | 0.00 | -0.11 | 8.84 |
| 2026-07-30 | ENTA | 0.00 | -0.11 | 8.84 |
| 2026-07-31 | ENTA | 0.00 | -0.11 | 8.84 |
| 2026-08-03 | ENTA | 0.00 | -0.04 | 8.84 |
| 2026-08-04 | ENTA | 0.00 | -0.04 | 8.84 |
| 2026-08-05 | ENTA | 0.00 | -0.04 | 8.84 |
| 2026-08-06 | ENTA | 0.00 | -0.04 | 8.84 |
| 2026-08-07 | ENTA | 0.00 | -0.04 | 8.84 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.45
Avg. EPS Est. Current Quarter
-0.51
Avg. EPS Est. Next Quarter
-0.63
Insider Transactions
Institutional Transactions
-0.04
Beta
0.94
Average Sales Estimate Current Quarter
17
Average Sales Estimate Next Quarter
17
Fair Value
Quality Score
29
Growth Score
26
Sentiment Score
90
Actual DrawDown %
86.5
Max Drawdown 5-Year %
-95.6
Target Price
21.57
P/E
Forward P/E
PEG
P/S
5.79
P/B
3.43
P/Free Cash Flow
EPS
-2.59
Average EPS Est. Cur. Y
-1.88
EPS Next Y. (Est.)
-2.05
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-89.56
Relative Volume
0.86
Return on Equity vs Sector %
-80.5
Return on Equity vs Industry %
-64.4
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.06
EBIT Estimation
◆
ENTA
Healthcare
$13.77
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
57
Range 1M
57%
Sup Dist
4.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
40.2%
EPS NY
9.8%
52W%
68.1%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+56.6% upside
Upside
+56.6%
Quality
29
ENTA — P/E HistoricalBiotechnology
Enanta Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 120
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis. It has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
ENTA
Latest News
—
Caricamento notizie per ENTA…
stock quote shares ENTA – Enanta Pharmaceuticals Inc Stock Price stock today
news today ENTA – Enanta Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ENTA – Enanta Pharmaceuticals Inc yahoo finance google finance
stock history ENTA – Enanta Pharmaceuticals Inc invest stock market
stock prices ENTA premarket after hours
ticker ENTA fair value insiders trading